Interestingly, similar to CD36, CAV1 expression levels were positively correlated with patient prognosis in TNBC and luminal subtypes of breast cancer (Figure 5F,H), whereas no significant correlation was observed in HER2‐positive breast cancer subtype (Figure 5G). Here, CAV1 is linked to breast carcinoma.